feed,title,long_url,short_url
MX,"Preliminary data suggest that ROS1 inhibitor, NVL-520, is well-tolerated and active in non-small cell lung cancer",https://medicalxpress.com/news/2022-10-preliminary-ros1-inhibitor-nvl-well-tolerated.html,https://bit.ly/3Fx8QR4
